Status:
COMPLETED
Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Cervix Cancer
Eligibility:
FEMALE
Brief Summary
The Cross Cancer Institute has recently acquired a tomotherapy radiotherapy treatment machine; the first of its kind in Canada. It has the potential to improve cancer treatment outcomes where radiothe...
Detailed Description
Megavoltage CT Imaging for Intracavitary Radiation Treatment in Cervix Cancer Proposal To assess the feasibility of performing CT imaging using a megavoltage CT scanner on five patients where remote...
Eligibility Criteria
Inclusion
- Patients undergoing brachytherapy for cervix cancer
Exclusion
- Patient refusal
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00124423
Start Date
June 1 2004
End Date
June 1 2007
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2